Professor Benjamin Besse

A medical oncologist specialising in the management of thoracic cancers, Professor Benjamin Besse has been the Director of Clinical Research at Gustave Roussy since 2nd September 2021, after having led the Institute's Department of Oncology Medicine for three years.

His main research areas include the application of molecular abnormalities to personalise treatment, circulating biomarkers, early drug development in thoracic tumours, NUT carcinomas, and thymic malignancies.

Benjamin Besse is the author and co-author of over 500 peer-reviewed articles. Over the past five years, he has been the principal investigator of more than thirty Phase I, II, and III clinical trials.

Professor Besse is responsible for the Scientific Chairs Council of the EORTC and coordinates the French network for thymic malignancies, RYTHMIC. He is also a member of ASCO (American Society of Clinical Oncology), IASLC (International Association for the Study of Lung Cancer), and ESMO (European Society for Medical Oncology). He is listed among Clarivate's Highly Cited Researchers.